Peer Review: Leaving Cerecor after a year, Peter Greenleaf starts a new CEO chapter at Aurinia — out to slay Restasis
→ A year after orchestrating Sucampo Pharma’s sale to Mallinckrodt, Peter Greenleaf is still in hot demand …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.